What is Prestige Brand Holdings Inc?
, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH · Verdict
Solid reward · low risk
PBH scores well on volatility and cash flow with no major weaknesses flagged in the model.
Based on 88% data coverage
PBH · Verdict
Top decile vs peers
23% free-cash-flow margin
17% net margin · 9% ROE
Interest covered 7.1×
P/E 11.5× · PEG 1.57
Model-based scoring. For information only — not financial advice.
, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 2.49B, and a P/E ratio of 14.7x.
The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.
A short list of Drug Manufacturers - Specialty & Generic names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 21,281 shares $83k | 0 |
| 9-12months | 1719 shares $43k | 0 |